ImportantFinancial Result Updates

Consolidated financial results show total income of ₹1,587 crore for the half-year, reflecting a year-over-year growth driven by strong demand and operational expansion.

Wockhardt Limited logo
Wockhardt LimitedWOCKPHARMA · Filed with the exchange

Despite the revenue growth, the company recorded a net loss of ₹333 crore, indicating pressures from operational costs and a challenging market environment.

Earnings per share (EPS) stood at -₹2.42. Operational costs rose to ₹1,602 crore, impacted significantly by higher employee benefits and finance costs.

The balance sheet remains robust, with total assets of ₹7,588 crore against total liabilities of ₹3,875 crore, providing a healthy equity cushion.

Wockhardt has announced a board meeting focused on strategic orientations, highlighting potential areas such as product diversification and market penetration.

Given the revenue growth coupled with ongoing cost pressures, the outlook calls for a cautious approach; thus, a hold stance is advisable as management works to enhance profitability and manage expenses.

Read the original filing(PDF)

No comments yet. Be the first.

More from Wockhardt Limited

All announcements